Fortress Biotech, Inc.·4

Nov 16, 5:46 PM ET

WEISS MICHAEL S 4

4 · Fortress Biotech, Inc. · Filed Nov 16, 2023

Insider Transaction Report

Form 4
Period: 2023-11-14
Transactions
  • Purchase

    COMMON STOCK, PAR VALUE $0.001

    2023-11-14$1.70/sh+147,058$249,9991,130,520 total
  • Purchase

    Warrants to purchase Common Stock

    2023-11-14+147,058147,058 total
    Exercise: $1.70From: 2023-11-14Exp: 2028-11-14Common Stock (147,058 underlying)
Footnotes (2)
  • [F1]Effective October 10, 2023, the Issuer effected a one-for-fifteen reverse stock split of its common stock (the "Reverse Split"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Split.
  • [F2]The shares of common stock and warrants to purchase common stock reflect on this Form 4 were purchased as units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock, at a price per unit of $1.70.

Documents

1 file
  • 4
    tm2330934-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT